• 1
    Epifanova OI. Mechanisms underlying the differential sensitivity of proliferating and resting cells to external factors. Intern Rev Cytol Suppl. 1977; 5: 303335.
  • 2
    Pardee AB, Dubrow R, Hamlin JL, Kletzien RF. Animal cell cycle. Annu Rev Biochem. 1978; 47: 715750.
  • 3
    Morris DR. Growth control of translation in mammalian cells. Prog Nucleic Acid Res Mol Biol. 1995; 51: 339363.
  • 4
    Raught B, Gingras AC, Sonenberg N. Regulation of ribosomal recruitment in eukaryotes. In: SonenbergN, HersheyJW, MathewsMB, editors. Translational control of gene expression. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 2000: 245293.
  • 5
    Rhoads RE, Joshi B, Minich WB. Participation of initiation factors in the recruitment of mRNA to ribosomes. Biochimie. 1994; 76: 831838.
  • 6
    Trachsel H. Binding of initiator methyionyl-tRNA to ribosomes. In: HersheyJW, MathewsMB, SonenbergN, editors. Translational control. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1996: 113139.
  • 7
    Hinnebusch AG. Mechanism and regulation of initiator methionyl-tRNA binding to ribosomes. In: SonenbergN, HersheyJW, MathewsMB, editors. Translational control of gene expression. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 2000: 185243.
  • 8
    Rosenwald IB, Rhoads DB, Callanan LD, Isselbacher KJ, Schmidt EV. Increased expression of eukaryotic translation initiation factors eIF-4E and eIF-2α in response to growth induction by c-myc. Proc Natl Acad Sci U S A. 1993; 90: 61756178.
  • 9
    Rosenwald IB. Upregulated expression of the genes encoding translation initiation factors eIF-4E and eIF-2α in transformed cells. Cancer Lett. 1996; 102: 113123.
  • 10
    Rosenwald IB. Growth factor-independent expression of the gene encoding translation initiation factor 4E in transformed cell lines. Cancer Lett. 1995; 98: 7782.
  • 11
    Rosenwald IB. Deregulation of protein synthesis as a mechanism of neoplastic transformation. Bioessays. 1996; 18: 243249.
  • 12
    Donze O, Jagus R, Koromilas AE, Hershey JW, Sonenberg N. Abrogation of translation initiation factor eIF-2 phosphorylation causes malignant transformation of NIH 3T3 cells. EMBO J. 1995; 14: 38283834.
  • 13
    Koromilas AE, Roy S, Barber GN, Katze MG, Sonenberg N. Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science. 1992; 257: 16851689.
  • 14
    De Benedetti A, Joshi-Barve S, Rinker-Schaffer C, Rhoads RE. Expression of antisense RNA against initiation factor eIF-4E mRNA in HeLa cells results in lengthened cell division times, diminished translation rates and reduced levels of both eIF-4E and p220 component of eIF-4F. Mol Cell Biol. 1991; 11: 54355445.
  • 15
    Rhoads RE. Protein synthesis, cell growth and oncogenesis. Curr Opin Cell Biol. 1991; 3: 10191024.
  • 16
    Hershey JW, Miyamoto S. Translational control and cancer. In: SonenbergN, HersheyJW, MathewsMB, editors. Translational control of gene expression. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 2000: 637654.
  • 17
    Dua K, Williams TM, Beretta L. Translational control of the proteome: relevance to cancer. Proteomics. 2001; 1: 11911199.
  • 18
    Watkins SJ, Norbury CJ. Translation initiation and its deregulation during tumorigenesis. Br J Cancer. 2002; 86: 10231027.
  • 19
    White RJ. Regulation of RNA polymerases I and III by the retinoblastoma protein: a mechanism for growth control? Trends Biochem Sci. 1997; 22: 7780.
  • 20
    Nathan CA, Liu L, Li BD, Abreo FW, Nandy I, DeBenedetti A. Detection of the proto-oncogene eIF-4E in surgical margins may predict recurrence in head and neck cancer. Oncogene. 1997; 5: 579584.
  • 21
    Rosenwald IB, Chen JJ, Wang S, Savas L, London IM, Pullman J. Upregulation of protein synthesis initiation factor eIF-4E is an early event during colon carcinogenesis. Oncogene. 1999; 18: 25072517.
  • 22
    Rosenwald IB, Hutzler M, Wang S, Chen JJ, Fraire A. Expression of translation initiation factors eIF-4E and eIF-2α is frequently increased in bronchioloalveolar but not in squamous carcinomas of the lung. Cancer. 2001; 92: 21642171.
  • 23
    Wang S, Lloyd RV, Hutzler MJ, et al. Expression of translation initiation factors 4E and 2alpha correlates with the progression of thyroid carcinoma. Thyroid. 2001; 11: 11011107.
  • 24
    Rosenwald IB, Lazaris-Karatzas A, Sonenberg N, Schmidt EV. Elevated expression of cyclin Dl in response to increases in initiation factor eIF-4E. Mol Cell Biol. 1993; 13: 73587363.
  • 25
    Rosenwald IB, Kaspar R, Rousseau D, et al. Eukaryotic translation initiation factor 4E regulates expression of cyclin Dl at transcriptional and post-transcriptional levels. J Biol Chem. 1995; 270: 2117621180.
  • 26
    Lobo MV, Martin ME, Perez MI, et al. Levels, phosphorylation status and cellular localization of translational factor eIF-2 in gastrointestinal carcinomas. Histochem J. 2000; 32: 139150.
  • 27
    Eberle J, Krasagakis K, Orfanos CE. Translation initiation factor eIF-4A1 mRNA is consistently overexpressed in human melanoma cells in vitro. Int J Cancer. 1997; 71: 396401.
  • 28
    Eberle J, Fecker LF, Bittner JU, Orfanos CE, Geilen CC. Decreased proliferation of human melanoma cell lines caused by antisense RNA against translation factor eIF-4AI. Br J Cancer. 2002; 86: 19571962.
  • 29
    Ender B, Lynch P, Kim YH, Inamdar NV, Cleary KR, Frazier ML. Overexpression of an elongation factor-1 gamma-hybridizing RNA in colorectal adenomas. Mol Carcinog. 1993; 7: 1820.
  • 30
    Mathur S, Cleary KR, Inamdar N, Kim YH, Steck P, Frazier ML. Overexpression of elongation factor-1 gamma protein in colorectal carcinoma. Cancer. 1998; 82: 816821.
  • 31
    Bartkova J, Lukas J, Guldberg P, et al. The p16-cyclinD/CDK4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis. Cancer Res. 1996; 56: 54755483.
  • 32
    Wang Y, Becker D. Differential expression of the cyclin-dependent kinase inhibitors p16 and p21 in the human melanocytic system. Oncogene. 1996; 12: 10691075.
  • 33
    Meric F, Hunt KK. Translation initiation in cancer: a novel target for therapy. Mol Cancer Ther. 2002; 1: 971979.
  • 34
    Caraglia M, Budillon A, Vitale G, Lupoli G, Tagliaferri P, Abbruzzese A. Modulation of molecular mechanisms involved in protein synthesis machinery as a new tool for the control of cell proliferation. Eur J Biochem. 2000; 267: 39193936.